In a study by Lewis-Wambi et al. (2011), BZA combined with conjugated estrogen was shown to reduce the proliferation of estrogen receptor (ER)-positive breast cancer cells by downregulating ERα and cyclin D1 [15]. The gene discussed is ESR1; the disease is breast cancer.